Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD -- Asia-Pacific Partner’s New Drug ...

Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs, today announced the dosing of the first patient in the Phase 2 trial of YA-101 for Multiple ...

Researchers at Penn Vet and the University of Padova identified a novel variant connected to progressive retinal atrophy ...

The journey of recovery and success requires resilience, adaptability, and perseverance, as seen in astronauts and ...

The Department for Work and Pensions (DWP) has released new data which reveals that over 1.1 million adults across the UK are ...

Frederic L.W.V.J. Schaper, MD, PhD , director of Epilepsy Network Mapping at the Center for Brain Circuit Therapeutics at ...

In collaboration with a foundation that breeds service dogs for the visually impaired, researchers at the School of ...